Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 33 | 2023 | 13104 | 2.370 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 13 | 2023 | 1692 | 2.010 |
Why?
|
Small Cell Lung Carcinoma | 7 | 2023 | 388 | 1.500 |
Why?
|
ras Proteins | 5 | 2016 | 1060 | 1.420 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2023 | 5223 | 1.350 |
Why?
|
Spheroids, Cellular | 6 | 2023 | 351 | 1.210 |
Why?
|
Protein Kinase Inhibitors | 17 | 2023 | 5534 | 1.050 |
Why?
|
Cell Line, Tumor | 41 | 2023 | 16690 | 0.970 |
Why?
|
Benzamides | 7 | 2018 | 1379 | 0.960 |
Why?
|
Nucleotides, Cyclic | 2 | 2020 | 81 | 0.880 |
Why?
|
Signal Transduction | 20 | 2021 | 23404 | 0.750 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3707 | 0.740 |
Why?
|
Neoplasms | 23 | 2023 | 21696 | 0.730 |
Why?
|
Interferons | 4 | 2021 | 706 | 0.710 |
Why?
|
Membrane Proteins | 5 | 2022 | 7882 | 0.680 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2133 | 0.680 |
Why?
|
Pyrimidines | 8 | 2018 | 2943 | 0.680 |
Why?
|
Drug Resistance, Neoplasm | 15 | 2023 | 5172 | 0.670 |
Why?
|
Endogenous Retroviruses | 2 | 2021 | 112 | 0.640 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1276 | 0.620 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 286 | 0.580 |
Why?
|
Platinum | 1 | 2018 | 233 | 0.580 |
Why?
|
Pyrimidinones | 1 | 2018 | 370 | 0.540 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2022 | 578 | 0.540 |
Why?
|
Adenocarcinoma | 4 | 2018 | 6364 | 0.520 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 78 | 0.510 |
Why?
|
Retinoblastoma Protein | 9 | 2019 | 705 | 0.510 |
Why?
|
Immunity, Innate | 4 | 2021 | 2962 | 0.510 |
Why?
|
Mutation | 25 | 2023 | 29786 | 0.500 |
Why?
|
Antineoplastic Agents | 11 | 2021 | 13693 | 0.500 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.490 |
Why?
|
Genes, ras | 3 | 2022 | 690 | 0.490 |
Why?
|
Gene Deletion | 4 | 2020 | 2751 | 0.480 |
Why?
|
Molecular Targeted Therapy | 5 | 2021 | 2725 | 0.480 |
Why?
|
Doxycycline | 1 | 2015 | 326 | 0.470 |
Why?
|
Autophagy | 3 | 2016 | 1297 | 0.460 |
Why?
|
Immunotherapy | 8 | 2023 | 4446 | 0.460 |
Why?
|
Pyridones | 1 | 2018 | 711 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1271 | 0.460 |
Why?
|
I-kappa B Kinase | 4 | 2019 | 252 | 0.450 |
Why?
|
Autocrine Communication | 1 | 2014 | 171 | 0.440 |
Why?
|
MAP Kinase Kinase 1 | 4 | 2020 | 335 | 0.430 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2020 | 11525 | 0.410 |
Why?
|
Mice | 39 | 2024 | 81201 | 0.410 |
Why?
|
Tumor Microenvironment | 9 | 2023 | 3590 | 0.400 |
Why?
|
Cell Survival | 5 | 2020 | 5882 | 0.390 |
Why?
|
Animals | 49 | 2024 | 168768 | 0.390 |
Why?
|
Neovascularization, Pathologic | 2 | 2022 | 2638 | 0.380 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2182 | 0.370 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2018 | 323 | 0.360 |
Why?
|
Chemokine CCL5 | 3 | 2016 | 209 | 0.360 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2017 | 2043 | 0.360 |
Why?
|
Melanoma | 5 | 2023 | 5511 | 0.350 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2009 | 82 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 8432 | 0.350 |
Why?
|
Endothelial Cells | 3 | 2023 | 3486 | 0.350 |
Why?
|
Pancreatitis | 1 | 2016 | 1092 | 0.330 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3143 | 0.330 |
Why?
|
Cell Nucleus | 6 | 2005 | 2969 | 0.330 |
Why?
|
Cytokines | 8 | 2023 | 7323 | 0.330 |
Why?
|
Humans | 96 | 2024 | 744366 | 0.320 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4262 | 0.300 |
Why?
|
MicroRNAs | 2 | 2021 | 3751 | 0.290 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.280 |
Why?
|
Microfluidics | 2 | 2022 | 662 | 0.280 |
Why?
|
Interleukin-6 | 4 | 2017 | 3203 | 0.270 |
Why?
|
Drug Design | 3 | 2021 | 1076 | 0.260 |
Why?
|
Mastocytosis, Systemic | 1 | 2006 | 100 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2018 | 539 | 0.250 |
Why?
|
Pyrazoles | 1 | 2015 | 1972 | 0.240 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2949 | 0.240 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6313 | 0.240 |
Why?
|
NF-kappa B | 3 | 2023 | 2499 | 0.240 |
Why?
|
RNA Interference | 4 | 2018 | 2890 | 0.240 |
Why?
|
Enzyme Activation | 4 | 2016 | 3702 | 0.230 |
Why?
|
Carbonic Anhydrases | 1 | 2024 | 115 | 0.230 |
Why?
|
Janus Kinases | 3 | 2023 | 244 | 0.230 |
Why?
|
Pyridines | 1 | 2015 | 2825 | 0.220 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2850 | 0.220 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10183 | 0.220 |
Why?
|
Gastroenteritis | 1 | 2004 | 245 | 0.210 |
Why?
|
Adrenergic Agents | 1 | 2022 | 70 | 0.210 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1678 | 0.210 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2023 | 4479 | 0.210 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 160 | 0.200 |
Why?
|
Receptor, Notch2 | 1 | 2021 | 89 | 0.200 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 164 | 0.190 |
Why?
|
Inflammation | 3 | 2020 | 10637 | 0.190 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2018 | 1821 | 0.180 |
Why?
|
Interferon Regulatory Factor-3 | 2 | 2018 | 123 | 0.180 |
Why?
|
Mesothelioma | 2 | 2016 | 818 | 0.180 |
Why?
|
Eosinophilia | 1 | 2004 | 541 | 0.180 |
Why?
|
Gene Amplification | 2 | 2022 | 1063 | 0.180 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 284 | 0.170 |
Why?
|
Coculture Techniques | 2 | 2020 | 1341 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 360 | 0.170 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 241 | 0.170 |
Why?
|
Ligands | 3 | 2022 | 3282 | 0.170 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 40 | 0.170 |
Why?
|
Immunity | 3 | 2022 | 1014 | 0.170 |
Why?
|
Transcription Factors | 7 | 2023 | 12207 | 0.160 |
Why?
|
Receptor, Notch1 | 1 | 2021 | 502 | 0.160 |
Why?
|
Ligases | 1 | 2020 | 333 | 0.160 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2917 | 0.160 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 290 | 0.160 |
Why?
|
Janus Kinase 1 | 1 | 2018 | 104 | 0.160 |
Why?
|
p120 GTPase Activating Protein | 1 | 2018 | 39 | 0.160 |
Why?
|
Cell Cycle | 3 | 2004 | 2967 | 0.160 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8861 | 0.160 |
Why?
|
RNA, Antisense | 1 | 2018 | 138 | 0.160 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2022 | 428 | 0.160 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 246 | 0.150 |
Why?
|
Apoptosis | 7 | 2023 | 9724 | 0.150 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2018 | 610 | 0.150 |
Why?
|
Flow Cytometry | 3 | 2017 | 5974 | 0.150 |
Why?
|
Microvessels | 1 | 2022 | 544 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2021 | 2943 | 0.150 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 320 | 0.150 |
Why?
|
Genomics | 6 | 2023 | 5717 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2020 | 3554 | 0.150 |
Why?
|
Hydroxamic Acids | 2 | 2017 | 494 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2018 | 1636 | 0.150 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7182 | 0.150 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.140 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 619 | 0.140 |
Why?
|
Telomerase | 1 | 2021 | 730 | 0.140 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4851 | 0.140 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 802 | 0.140 |
Why?
|
Mice, Nude | 2 | 2023 | 3689 | 0.130 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2015 | 31 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 730 | 0.130 |
Why?
|
Oxo-Acid-Lyases | 1 | 2015 | 22 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 350 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1023 | 0.130 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5263 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 647 | 0.130 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18034 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1903 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1097 | 0.130 |
Why?
|
Leukemia, Hairy Cell | 1 | 2015 | 82 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2014 | 17 | 0.130 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 528 | 0.130 |
Why?
|
RNA, Double-Stranded | 3 | 2021 | 290 | 0.130 |
Why?
|
High-Throughput Screening Assays | 2 | 2018 | 944 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2017 | 789 | 0.130 |
Why?
|
Neovascularization, Physiologic | 1 | 2022 | 1351 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2019 | 4208 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1624 | 0.120 |
Why?
|
raf Kinases | 1 | 2014 | 122 | 0.120 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 268 | 0.120 |
Why?
|
Phosphoproteins | 2 | 2018 | 2441 | 0.120 |
Why?
|
RNA Splice Sites | 1 | 2015 | 209 | 0.120 |
Why?
|
Off-Label Use | 1 | 2015 | 169 | 0.120 |
Why?
|
Drug Resistance | 1 | 2020 | 1608 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 188 | 0.110 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 391 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 250 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2504 | 0.110 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 9445 | 0.110 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 225 | 0.110 |
Why?
|
NIH 3T3 Cells | 3 | 2018 | 677 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.110 |
Why?
|
Diplopia | 1 | 2014 | 200 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 850 | 0.110 |
Why?
|
Hemianopsia | 1 | 2014 | 122 | 0.110 |
Why?
|
Immunophenotyping | 1 | 2017 | 1880 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
Tamoxifen | 1 | 2017 | 981 | 0.110 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5692 | 0.110 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2013 | 323 | 0.110 |
Why?
|
Treatment Failure | 1 | 2018 | 2618 | 0.110 |
Why?
|
Cell Proliferation | 8 | 2020 | 10483 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2938 | 0.100 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2004 | 2104 | 0.100 |
Why?
|
Testicular Hormones | 2 | 2003 | 188 | 0.100 |
Why?
|
Gait Disorders, Neurologic | 1 | 2014 | 231 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 607 | 0.100 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2014 | 294 | 0.100 |
Why?
|
Breast Neoplasms | 6 | 2023 | 20824 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1585 | 0.100 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 828 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 3524 | 0.090 |
Why?
|
DNA Replication | 3 | 2004 | 1399 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2020 | 1723 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1862 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 2016 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2023 | 2916 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2013 | 409 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2023 | 9735 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.090 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2417 | 0.090 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4740 | 0.090 |
Why?
|
DNA | 1 | 2004 | 7294 | 0.090 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 379 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1851 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12262 | 0.090 |
Why?
|
Genes, Lethal | 1 | 2009 | 242 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1376 | 0.080 |
Why?
|
Nuclear Proteins | 5 | 2023 | 5856 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1580 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1012 | 0.080 |
Why?
|
Fibroblasts | 4 | 2021 | 4162 | 0.080 |
Why?
|
bcl-X Protein | 1 | 2009 | 411 | 0.080 |
Why?
|
Antigen Presentation | 2 | 2023 | 1284 | 0.080 |
Why?
|
Male | 17 | 2021 | 350115 | 0.080 |
Why?
|
S Phase | 3 | 2004 | 423 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2259 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1031 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3799 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2021 | 57776 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3481 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2017 | 1038 | 0.070 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2014 | 671 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5524 | 0.070 |
Why?
|
Oncogenes | 2 | 2010 | 1265 | 0.070 |
Why?
|
Female | 23 | 2023 | 380193 | 0.070 |
Why?
|
Cell Cycle Proteins | 4 | 2020 | 3464 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4805 | 0.070 |
Why?
|
Organoids | 2 | 2023 | 701 | 0.070 |
Why?
|
DEAD-box RNA Helicases | 2 | 2023 | 375 | 0.070 |
Why?
|
Cell Nucleolus | 2 | 2004 | 166 | 0.070 |
Why?
|
Lamin Type A | 2 | 2004 | 190 | 0.070 |
Why?
|
Histone Deacetylases | 3 | 2017 | 728 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 21833 | 0.070 |
Why?
|
Middle Aged | 10 | 2021 | 213390 | 0.070 |
Why?
|
Acute Disease | 1 | 2016 | 7147 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 3505 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1879 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9240 | 0.060 |
Why?
|
Glycoproteins | 2 | 2003 | 2266 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3514 | 0.060 |
Why?
|
Prognosis | 3 | 2023 | 29060 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11366 | 0.060 |
Why?
|
DNA Polymerase III | 1 | 2004 | 55 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 41 | 0.060 |
Why?
|
Antibodies, Antinuclear | 1 | 2004 | 326 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2020 | 14561 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3638 | 0.060 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2004 | 285 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 168 | 0.050 |
Why?
|
Piperazines | 2 | 2019 | 2488 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2014 | 3476 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 776 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2014 | 2566 | 0.050 |
Why?
|
Proteins | 3 | 2003 | 6100 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 182 | 0.050 |
Why?
|
Laparotomy | 1 | 2004 | 473 | 0.050 |
Why?
|
Immunoblotting | 2 | 2017 | 1683 | 0.050 |
Why?
|
Chemokine CXCL10 | 1 | 2023 | 305 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7798 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2003 | 315 | 0.050 |
Why?
|
Histones | 2 | 2004 | 2598 | 0.050 |
Why?
|
Cysteine Endopeptidases | 1 | 2004 | 563 | 0.050 |
Why?
|
Rubidium | 1 | 2000 | 133 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 705 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 40559 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 8987 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15520 | 0.050 |
Why?
|
Interphase | 1 | 2001 | 226 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 686 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 1525 | 0.050 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2000 | 113 | 0.050 |
Why?
|
History, 21st Century | 1 | 2006 | 1534 | 0.050 |
Why?
|
Cyclin E | 1 | 2000 | 172 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2023 | 1369 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1574 | 0.040 |
Why?
|
Protein Binding | 3 | 2021 | 9384 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 321 | 0.040 |
Why?
|
Aged | 7 | 2021 | 163288 | 0.040 |
Why?
|
Cell Count | 1 | 2004 | 1856 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3047 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 1142 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 2000 | 385 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6234 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
Mast Cells | 1 | 2006 | 1544 | 0.040 |
Why?
|
Virus Internalization | 1 | 2023 | 502 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2014 | 2012 | 0.040 |
Why?
|
Transfection | 3 | 2021 | 5895 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12961 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 49 | 0.040 |
Why?
|
Genome, Human | 3 | 2021 | 4420 | 0.040 |
Why?
|
Luciferases, Firefly | 1 | 2018 | 46 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1081 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2005 | 1149 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2740 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2019 | 212 | 0.040 |
Why?
|
Introns | 1 | 2021 | 992 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 6933 | 0.040 |
Why?
|
Intestine, Small | 1 | 2004 | 1240 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4569 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
Up-Regulation | 2 | 2019 | 4222 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11126 | 0.040 |
Why?
|
Cell Line | 5 | 2004 | 16000 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8436 | 0.040 |
Why?
|
Drug Discovery | 2 | 2020 | 1058 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 861 | 0.040 |
Why?
|
Binding Sites | 3 | 2014 | 6111 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1602 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 994 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 63107 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
Cisplatin | 1 | 2023 | 1662 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1434 | 0.030 |
Why?
|
HeLa Cells | 2 | 2020 | 3130 | 0.030 |
Why?
|
Ovary | 1 | 2000 | 981 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 364 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 892 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1988 | 0.030 |
Why?
|
Acetoacetates | 1 | 2015 | 22 | 0.030 |
Why?
|
Serine | 1 | 2019 | 826 | 0.030 |
Why?
|
Butyrates | 1 | 1996 | 163 | 0.030 |
Why?
|
Genome | 2 | 2017 | 1807 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
Antibodies | 1 | 2024 | 2460 | 0.030 |
Why?
|
Albumins | 1 | 2018 | 568 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2004 | 2108 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
Quinolines | 1 | 2020 | 732 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3519 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 13814 | 0.030 |
Why?
|
Chromatin | 2 | 2004 | 2933 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1340 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2716 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p107 | 2 | 2004 | 74 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3207 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2018 | 826 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2327 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2110 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2021 | 11486 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1423 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13882 | 0.030 |
Why?
|
Cell Lineage | 1 | 2022 | 2504 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 2027 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7721 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 874 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1794 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p130 | 2 | 2003 | 76 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3511 | 0.030 |
Why?
|
Laparoscopy | 1 | 2004 | 2150 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 199 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3001 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 3024 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3279 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1708 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 1101 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18111 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1970 | 0.020 |
Why?
|
Metabolome | 1 | 2017 | 895 | 0.020 |
Why?
|
Models, Genetic | 1 | 2020 | 3493 | 0.020 |
Why?
|
Nervous System Neoplasms | 1 | 2010 | 91 | 0.020 |
Why?
|
Anti-Mullerian Hormone | 2 | 2003 | 402 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1793 | 0.020 |
Why?
|
Base Sequence | 1 | 2021 | 12797 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2019 | 1363 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5451 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 12073 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 104 | 0.020 |
Why?
|
Fatty Acids | 1 | 2017 | 1809 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3130 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1524 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2021 | 19233 | 0.020 |
Why?
|
Phenotype | 2 | 2022 | 16367 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2887 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3921 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 971 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 5023 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1783 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2014 | 1581 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3848 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 890 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 1941 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2008 | 674 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2736 | 0.020 |
Why?
|
Adult | 3 | 2021 | 214052 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9647 | 0.010 |
Why?
|
Mullerian Ducts | 1 | 2003 | 198 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2004 | 443 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 898 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 1161 | 0.010 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2001 | 19 | 0.010 |
Why?
|
E2F4 Transcription Factor | 1 | 2001 | 36 | 0.010 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 2001 | 142 | 0.010 |
Why?
|
Transcription Factor DP1 | 1 | 2001 | 141 | 0.010 |
Why?
|
Ovarian Neoplasms | 2 | 2013 | 4839 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13286 | 0.010 |
Why?
|
Lamins | 1 | 2000 | 36 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2001 | 349 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2001 | 277 | 0.010 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2001 | 112 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2000 | 191 | 0.010 |
Why?
|
Culture Techniques | 1 | 2000 | 554 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2003 | 590 | 0.010 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2000 | 250 | 0.010 |
Why?
|
G1 Phase | 1 | 2000 | 415 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 1454 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2004 | 1335 | 0.010 |
Why?
|
Butyric Acid | 1 | 1996 | 55 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39052 | 0.010 |
Why?
|
Antigens, Viral, Tumor | 1 | 1996 | 156 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5181 | 0.010 |
Why?
|
Blood Proteins | 1 | 2000 | 1124 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56429 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 2649 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 53290 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2700 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2020 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72296 | 0.010 |
Why?
|
Telomere | 1 | 1996 | 910 | 0.010 |
Why?
|
Rats | 1 | 2003 | 24252 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9584 | 0.000 |
Why?
|